BioMérieux Gets FDA Approval for Expanded Vitek MS Rapid Pathogen Identification

BioMérieux Gets FDA Approval for Expanded Vitek MS Rapid Pathogen Identification

HTTP/1.1 200 OK Date: Tue, 01 Aug 2017 08:16:09 GMT Content-Type: text/html; charset=utf-8 Transfer-Encoding: chunked Connection: keep-alive Cache-Control: no-cache, must-revalidate Content-Language: en Expires: Sun, 19 Nov 1978 05:00:00 GMT Link: ; rel="canonical",; rel="shortlink" Surrogate-Key: yhzG1o7SVGs+GcuqK5Xk 3SEX1YZXubievjMD6Vq3 Surrogate-Key-Raw: X-Content-Type-Options: nosniff X-Drupal-Cache: MISS X-Frame-Options: SAMEORIGIN X-Pantheon-Environment: live X-Pantheon-Phpreq: yes X-Pantheon-Site: 025e433e-4745-4e86-bd6a-9fb252581f65 X-Pantheon-Styx-Hostname: styx2dc46933 X-Styx-Req-Id: styx-ab54dab4e1672baff1240b0f05943f72 xkey: yhzG1o7SVGs+GcuqK5Xk 3SEX1YZXubievjMD6Vq3 X-Varnish: 706574643 Age: 0 Via: 1.1 varnish-v4 Vary: Accept-Encoding, Cookie Server: cloudflare-nginx CF-RAY: 38775a89691c7131-ORD BioMérieux Gets FDA Approval for Expanded Vitek MS Rapid Pathogen Identification | GenomeWeb

Pay Someone To Write A Literature Review

NEW YORK (GenomeWeb) –BioMérieux said today that the Vitek MS MALDI-TOF Mass Spectrometry System for rapid pathogen identification has received 510(k) clearance from the US Food and Drug Administration for the expanded identification of mycobacteria,Nocardia,and molds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Custom Written Research Papers

Already have an account?
.

Defending Your Dissertation Proposal Read more